--- title: "Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results | PLX Stock News" type: "News" locale: "en" url: "https://longbridge.com/en/news/286245455.md" description: "Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results | PLX Stock News" datetime: "2026-05-13T02:50:35.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286245455.md) - [en](https://longbridge.com/en/news/286245455.md) - [zh-HK](https://longbridge.com/zh-HK/news/286245455.md) --- # Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results | PLX Stock News Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results | PLX Stock News ### Related Stocks - [PLX.US](https://longbridge.com/en/quote/PLX.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) ## Related News & Research - [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md) - [Capricor publishes investor presentation on deramiocel Duchenne muscular dystrophy program](https://longbridge.com/en/news/287222906.md) - [Eton Secures U.S. IMPAVIDO Rights; $4.25M Fees, Up To $4M Milestones And 50-55% Revenue Share](https://longbridge.com/en/news/286966420.md) - [Neurothera Labs Announces Adoption of Semi-Annual Reporting](https://longbridge.com/en/news/287119698.md) - [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)